NOTICE OF INTENT FOR SOMASCAN ASSAY KITS
Contract Opportunity Analysis
NIAID, part of the National Institutes of Health within HHS, intends to make a sole-source, firm-fixed-price purchase order to SomaLogic Operating Co., Inc. for SomaScan 7K and 11K assay kits to support the Center for Human Immunology and related NIH research and clinical trials. The acquisition covers 15 kits for analysis of clinical samples including serum, plasma, cell lysates, tissue homogenates, urine, and cerebrospinal fluid, using a platform that measures up to 11,000 proteins with low sample volume and high reproducibility. The need is tied to ongoing sample batching work at CHI and the requirement to preserve data comparability with previously generated longitudinal results, with performance expected for a one-year period and delivery to Bethesda, Maryland. The stated acquisition value is $522,030, and interested parties with comparable capabilities may submit a capability statement by 5:00 pm EST on May 13, 2026.